Trials / Terminated
TerminatedNCT00455637
Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy?
A Phase II, Randomised, Double-blind, Dose-ranging Study in Children and Young People to Determine the Optimal Dose of Botulinum Toxin Type-A (Dysport®) in Managing the Symptoms of Hip Muscle Spasticity Due to Cerebral Palsy
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- 4 Years – 16 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to compare the effectiveness of 3 doses of Dysport (5, 10 or 15 Units/Kg/hip) in the management of chronic bilateral hip pain due to cerebral palsy in children/young people.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Botulinum toxin type A |
Timeline
- Start date
- 2007-03-01
- Primary completion
- 2008-03-17
- Completion
- 2008-03-17
- First posted
- 2007-04-04
- Last updated
- 2019-08-02
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00455637. Inclusion in this directory is not an endorsement.